Glenmark Pharmaceuticals Limited (GLENMARK) Price & Analysis

Compare

0 Followers

GLENMARK Stock Chart & Stats

Day’s Range― - ―

52-Week Range₹1,176.00 - ₹1,830.05

Previous CloseN/A

Volume301.32K

Average Volume (3M)32.64K

Market Cap

₹427.58B

Enterprise ValueN/A

Total Cash (Recent Filing)₹16.59B

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)42.7

Beta0.94

Next Earnings

Aug 08, 2025

EPS EstimateN/A

Last Dividend Ex-Date

Sep 13, 2024

Dividend Yield0.17%

Share Statistics

EPS (TTM)10.40

Shares Outstanding282,200,800

10 Day Avg. Volume77,541

30 Day Avg. Volume32,641

Financial Highlights & Ratios

PEG Ratio-2.77

Price to Book (P/B)4.60

Price to Sales (P/S)0.00

P/FCF Ratio132.09

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

₹1,785.00

Price Target Upside25.83% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

Glenmark Pharmaceuticals Limited News

PremiumCompany Announcements

Glenmark Pharmaceuticals Launches Vancomycin Hydrochloride Injection in the US

2M ago

PremiumCompany Announcements

Glenmark Subsidiary to Cease Manufacturing in Switzerland

2M ago

See All IN:GLENMARK News

See All News >

Financials

Income Statement >

GLENMARK FAQ

What was Glenmark Pharmaceuticals Limited’s price range in the past 12 months?

Glenmark Pharmaceuticals Limited lowest stock price was ₹1176.00 and its highest was ₹1830.05 in the past 12 months.

What is Glenmark Pharmaceuticals Limited’s market cap?

Glenmark Pharmaceuticals Limited’s market cap is ₹427.58B.

When is Glenmark Pharmaceuticals Limited’s upcoming earnings report date?

Glenmark Pharmaceuticals Limited’s upcoming earnings report date is Aug 08, 2025 which is in 62 days.

How were Glenmark Pharmaceuticals Limited’s earnings last quarter?

Glenmark Pharmaceuticals Limited released its earnings results on May 23, 2025. The company reported ₹10.4 earnings per share for the quarter, missing the consensus estimate of ₹12.1 by -₹1.7.

Is Glenmark Pharmaceuticals Limited overvalued?

According to Wall Street analysts Glenmark Pharmaceuticals Limited’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Glenmark Pharmaceuticals Limited pay dividends?

Glenmark Pharmaceuticals Limited pays a Annually dividend of ₹2.5 which represents an annual dividend yield of 0.17%. See more information on Glenmark Pharmaceuticals Limited dividends here

What is Glenmark Pharmaceuticals Limited’s EPS estimate?

Glenmark Pharmaceuticals Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Glenmark Pharmaceuticals Limited have?

Glenmark Pharmaceuticals Limited has 282,200,800 shares outstanding.

What happened to Glenmark Pharmaceuticals Limited’s price movement after its last earnings report?

Glenmark Pharmaceuticals Limited reported an EPS of ₹10.4 in its last earnings report, missing expectations of ₹12.1. Following the earnings report the stock price went down -0.873%.

Which hedge fund is a major shareholder of Glenmark Pharmaceuticals Limited?

Currently, no hedge funds are holding shares in IN:GLENMARK

GLENMARK Stock 12 Month Forecast

Average Price Target

₹1,785.00

▲(25.83%Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1053":"₹1,053","1786":"₹1,786","1236.25":"₹1,236.3","1419.5":"₹1,419.5","1602.75":"₹1,602.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1785,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹1.78K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1785,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹1.78K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1785,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹1.78K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1053,1236.25,1419.5,1602.75,1786],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1380.55,1411.6615384615384,1442.7730769230768,1473.8846153846152,1504.996153846154,1536.1076923076923,1567.2192307692308,1598.3307692307692,1629.4423076923076,1660.5538461538463,1691.6653846153845,1722.7769230769231,1753.8884615384616,{"y":1785,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1380.55,1411.6615384615384,1442.7730769230768,1473.8846153846152,1504.996153846154,1536.1076923076923,1567.2192307692308,1598.3307692307692,1629.4423076923076,1660.5538461538463,1691.6653846153845,1722.7769230769231,1753.8884615384616,{"y":1785,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1380.55,1411.6615384615384,1442.7730769230768,1473.8846153846152,1504.996153846154,1536.1076923076923,1567.2192307692308,1598.3307692307692,1629.4423076923076,1660.5538461538463,1691.6653846153845,1722.7769230769231,1753.8884615384616,{"y":1785,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1054.64,"date":1714521600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1159.09,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1263.89,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1436.34,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1685.58,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1666.7,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1693.3,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1550,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1614.05,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1452.5,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1278.75,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1278.75,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1380.55,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >